Drug Type Small molecule drug |
Synonyms Multicyclic 2-aminothiazole carboxamide that inhibits tubulin polymerization |
Action inhibitors |
Mechanism Microtubule-associated proteins inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain metastases | Preclinical | United States | 10 May 2024 | |
Breast Cancer | Preclinical | United States | 18 Apr 2023 | |
Glioblastoma | Preclinical | United States | 18 Apr 2023 | |
Lung Cancer | Preclinical | United States | 18 Apr 2023 | |
Melanoma | Preclinical | United States | 18 Apr 2023 |